We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Brighter AB (BRIG) SEK0.05

Sell:0.093 SEK Buy:0.0939 SEK Change: 0.0012 SEK (1.29%)
Market closed |  Prices as at close on 23 June 2022 | Switch to live prices |
Sell:0.093 SEK
Buy:0.0939 SEK
Change: 0.0012 SEK (1.29%)
Market closed |  Prices as at close on 23 June 2022 | Switch to live prices |
Sell:0.093 SEK
Buy:0.0939 SEK
Change: 0.0012 SEK (1.29%)
Market closed |  Prices as at close on 23 June 2022 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Brighter AB (publ) is a Sweden-based technology company engaged in the healthcare sector. The Company offers solutions related to diabetes care, welfare technology and digital healthcare services. Brighter AB (publ) is a Parent Company, that operates through group of subsidiaries. The group’s main purpose is to improve health and wellbeing amongst the global population through development of technical and digital medical devices with a primary area of application in the treatment of diabetes. The Company reports the following operating segments: Brighter, Camanio and Nectarine Health.

Contact details

Address:
Borgarfjordsgatan 18
KISTA
164 40
Sweden
Telephone:
+46 (8) 55008820
Website:
https://brighter.se/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
BRIG
ISIN:
SE0004019545
Market cap:
67.95 million SEK
Shares in issue:
473.05 million
Sector:
Health Care Equipment
Exchange:
Stockholm Stock Exchange
Country:
Sweden
Currency:
Swedish Krona
Indices:
n/a

Key personnel

  • Christer Traegardh
    Chairman of the Board
  • Erik Lissner
    Chief Executive Officer
  • Christopher Robinson
    Chief Financial Officer
  • Jonas Johansson
    Head of Research and Development
  • Marie-Louise Kanon
    Head of Communication and Brand
  • Johan Moller
    Head of Sales and Marketing
  • Maja Roslund
    Head of People and Culture
  • Dragan Zdravkovic
    Head of Medical Affairs

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.